One Chain Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

One Chain General Information

Description

Developer of biomedicines designed to provide immunotherapies against hematological neoplasms. The company's biomedicines aim to offer treatments based on immunotherapy for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), enabling patients to receive effective treatment for malignancies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Calle Muntaner 383, 3rd 2nd
  • 08021 Barcelona
  • Spain
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Calle Muntaner 383, 3rd 2nd
  • 08021 Barcelona
  • Spain

One Chain Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

One Chain Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 21-Feb-2025 Completed Clinical Trials - General
4. Early Stage VC 22-Jun-2023 Completed Clinical Trials - General
3. Grant 23-Feb-2023 Completed Clinical Trials - General
2. Seed Round 20-Jul-2020 $3.44M $3.44M Completed Generating Revenue
1. Spin-Off 01-Jun-2020 Completed Generating Revenue
To view One Chain’s complete valuation and funding history, request access »

One Chain Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view One Chain’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

One Chain Patents

One Chain Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024221674-A1 Ccr9 targeting moiety for the treatment of ccr9-positive cancer Pending 15-Feb-2023
EP-4417623-A1 Ccr9 targeting moiety for the treatment of ccr9-positive cancer Inactive 15-Feb-2023
EP-4665760-A1 Ccr9 targeting moiety for the treatment of ccr9-positive cancer Pending 15-Feb-2023
US-20260232732-A1 Ccr9 targeting moiety for the treatment of ccr9-positive cancer Pending 15-Feb-2023
WO-2024170627-A1 Ccr9 targeting moiety for the treatment of ccr9-positive cancer Inactive 15-Feb-2023 A61K40/11
To view One Chain’s complete patent history, request access »

One Chain Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

One Chain Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biocat Accelerator/Incubator
Clave (Pamplona) Venture Capital Minority
Nara Capital AM Fund of Funds Minority
European Commission Government
INNVIERTE SICC Government Minority
You’re viewing 5 of 7 investors. Get the full list »

One Chain FAQs

  • When was One Chain founded?

    One Chain was founded in 2020.

  • Where is One Chain headquartered?

    One Chain is headquartered in Barcelona, Spain.

  • What is the size of One Chain?

    One Chain has 21 total employees.

  • What industry is One Chain in?

    One Chain’s primary industry is Drug Discovery.

  • Is One Chain a private or public company?

    One Chain is a Private company.

  • What is One Chain’s current revenue?

    The current revenue for One Chain is .

  • How much funding has One Chain raised over time?

    One Chain has raised $10.7M.

  • Who are One Chain’s investors?

    Biocat, Clave (Pamplona), Nara Capital AM, European Commission, and INNVIERTE SICC are 5 of 7 investors who have invested in One Chain.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process